Search
Orthofix Medical Inc
OFIXAdd to Watchlist
12.010USD
-0.280-2.28%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
485.46MMarket Cap
LossP/E TTM
More Details of Orthofix Medical Inc Company
Orthofix Medical Inc. is a global medical technology company. The Company offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
Orthofix Medical Inc Info
Ticker SymbolOFIX
Company nameOrthofix Medical Inc
IPO dateApr 24, 1992
CEOCalafiore (Massimo)
Number of employees1616
Security typeOrdinary Share
Fiscal year-endApr 24
Address3451 Plano Pkwy
CityLEWISVILLE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code75056-9453
Phone12149372000
Websitehttps://ir.orthofix.com/ir-home/default.aspx
Ticker SymbolOFIX
IPO dateApr 24, 1992
CEOCalafiore (Massimo)
Company Executives of Orthofix Medical Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Massimo Calafiore
Mr. Massimo Calafiore
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
99.09K
-24.73%
Mr. Jason M. Hannon
Mr. Jason M. Hannon
Independent Director
Independent Director
71.57K
+2.69%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Director
Independent Director
60.21K
+28.11%
Mr. Michael M. Finegan
Mr. Michael M. Finegan
Independent Chairman of the Board
Independent Chairman of the Board
59.02K
+5.45%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
54.07K
--
Mr. Max Reinhardt
Mr. Max Reinhardt
President - Global Spine
President - Global Spine
10.73K
+90.46%
Mr. Patrick G. Fisher
Mr. Patrick G. Fisher
President - Global Orthopedics
President - Global Orthopedics
9.50K
-401.26%
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Lucas Vitale
Mr. Lucas Vitale
Chief People and Business Operations Officer
Chief People and Business Operations Officer
--
--
Mr. J. Andres Cedron
Mr. J. Andres Cedron
Chief Legal Officer
Chief Legal Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Massimo Calafiore
Mr. Massimo Calafiore
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
99.09K
-24.73%
Mr. Jason M. Hannon
Mr. Jason M. Hannon
Independent Director
Independent Director
71.57K
+2.69%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Director
Independent Director
60.21K
+28.11%
Mr. Michael M. Finegan
Mr. Michael M. Finegan
Independent Chairman of the Board
Independent Chairman of the Board
59.02K
+5.45%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
54.07K
--
Mr. Max Reinhardt
Mr. Max Reinhardt
President - Global Spine
President - Global Spine
10.73K
+90.46%
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Spinal Implants
440.49M
53.57%
Bone Growth Therapies
247.16M
30.06%
By RegionUSD
Name
Revenue
Proportion
United States
684.07M
83.19%
Others
76.73M
9.33%
Italy
22.28M
2.71%
United Kingdom
13.33M
1.62%
France (Country)
11.96M
1.45%
Other
13.94M
1.70%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Spinal Implants
440.49M
53.57%
Bone Growth Therapies
247.16M
30.06%
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Engine Capital Management, LP
11.32%
Juniper Investment Company, LLC
9.36%
Rubric Capital Management LP
9.21%
Paradigm Capital Management, Inc.
8.18%
BlackRock Institutional Trust Company, N.A.
7.02%
Other
54.92%
Shareholders
Shareholders
Proportion
Engine Capital Management, LP
11.32%
Juniper Investment Company, LLC
9.36%
Rubric Capital Management LP
9.21%
Paradigm Capital Management, Inc.
8.18%
BlackRock Institutional Trust Company, N.A.
7.02%
Other
54.92%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
43.14%
Hedge Fund
24.20%
Investment Advisor
19.89%
Research Firm
1.93%
Individual Investor
1.86%
Bank and Trust
0.21%
Pension Fund
0.13%
Insurance Company
0.03%
Other
8.60%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
334
38.26M
94.72%
-2.01M
2025Q4
332
35.98M
90.87%
-4.32M
2025Q3
360
36.43M
92.00%
-1.48M
2025Q2
383
34.24M
86.73%
-7.53M
2025Q1
400
36.08M
92.22%
-6.00M
2024Q4
406
35.79M
91.88%
-7.42M
2024Q3
405
37.21M
98.94%
-7.35M
2024Q2
405
38.09M
101.30%
-7.13M
2024Q1
403
37.91M
101.53%
-6.95M
2023Q4
403
37.82M
103.01%
-4.07M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Engine Capital Management, LP
4.39M
10.94%
+137.86K
+3.24%
Feb 25, 2026
Juniper Investment Company, LLC
3.78M
9.43%
+274.28K
+7.81%
Feb 11, 2026
Rubric Capital Management LP
3.72M
9.27%
--
--
Dec 31, 2025
Paradigm Capital Management, Inc.
3.30M
8.23%
-39.60K
-1.18%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
2.84M
7.07%
+7.53K
+0.27%
Dec 31, 2025
Armistice Capital LLC
2.65M
6.6%
+412.00K
+18.43%
Dec 31, 2025
Millennium Management LLC
1.44M
3.59%
-34.45K
-2.33%
Dec 31, 2025
Philosophy Capital Management LLC
1.02M
2.53%
+131.59K
+14.89%
Dec 31, 2025
Geode Capital Management, L.L.C.
947.19K
2.36%
+5.87K
+0.62%
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
0.7%
Invesco NASDAQ Future Gen 200 ETF
0.55%
Inspire Small/Mid Cap ESG ETF
0.22%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.12%
iShares Micro-Cap ETF
0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.1%
Texas Capital Texas Small Cap Equity Index ETF
0.09%
iShares U.S. Medical Devices ETF
0.07%
Avantis US Small Cap Equity ETF
0.06%
Texas Capital Texas Equity Index ETF
0.05%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion0.7%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.55%
Inspire Small/Mid Cap ESG ETF
Proportion0.22%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proportion0.12%
iShares Micro-Cap ETF
Proportion0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.1%
Texas Capital Texas Small Cap Equity Index ETF
Proportion0.09%
iShares U.S. Medical Devices ETF
Proportion0.07%
Avantis US Small Cap Equity ETF
Proportion0.06%
Texas Capital Texas Equity Index ETF
Proportion0.05%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
